RS63704B1 - Nova kompozicija acetaminofen jedinjenja bez neželjenog efekta na jetru - Google Patents

Nova kompozicija acetaminofen jedinjenja bez neželjenog efekta na jetru

Info

Publication number
RS63704B1
RS63704B1 RS20221004A RSP20221004A RS63704B1 RS 63704 B1 RS63704 B1 RS 63704B1 RS 20221004 A RS20221004 A RS 20221004A RS P20221004 A RSP20221004 A RS P20221004A RS 63704 B1 RS63704 B1 RS 63704B1
Authority
RS
Serbia
Prior art keywords
liver
side effect
compound composition
acetaminophen compound
new
Prior art date
Application number
RS20221004A
Other languages
English (en)
Inventor
Oliver Yao-Pu Hu
Tung-Yuan Shih
Original Assignee
National Defense Education And Res Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Defense Education And Res Foundation filed Critical National Defense Education And Res Foundation
Publication of RS63704B1 publication Critical patent/RS63704B1/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
RS20221004A 2013-11-13 2013-11-13 Nova kompozicija acetaminofen jedinjenja bez neželjenog efekta na jetru RS63704B1 (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13897632.9A EP3069733B1 (en) 2013-11-13 2013-11-13 New acetaminophen compound composition without side effect to liver
PCT/CN2013/087049 WO2015070396A1 (zh) 2013-11-13 2013-11-13 无肝副作用的对乙酰胺基酚新复方组合

Publications (1)

Publication Number Publication Date
RS63704B1 true RS63704B1 (sr) 2022-11-30

Family

ID=53056618

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20221004A RS63704B1 (sr) 2013-11-13 2013-11-13 Nova kompozicija acetaminofen jedinjenja bez neželjenog efekta na jetru

Country Status (15)

Country Link
US (3) US10420737B2 (sr)
EP (2) EP4173619A3 (sr)
JP (1) JP2016520100A (sr)
KR (2) KR102017550B1 (sr)
CN (2) CN105188756B (sr)
DK (1) DK3069733T3 (sr)
EA (1) EA029454B1 (sr)
ES (1) ES2929945T3 (sr)
HR (1) HRP20221344T1 (sr)
HU (1) HUE060309T2 (sr)
LT (1) LT3069733T (sr)
PL (1) PL3069733T3 (sr)
PT (1) PT3069733T (sr)
RS (1) RS63704B1 (sr)
WO (1) WO2015070396A1 (sr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015070396A1 (zh) * 2013-11-13 2015-05-21 财团法人国防教育研究基金会 无肝副作用的对乙酰胺基酚新复方组合
CN107614475A (zh) * 2015-09-24 2018-01-19 欣耀生医股份有限公司 有效于治疗肝毒性及脂肪肝疾病的化合物及其用途
JP2018534323A (ja) * 2015-11-19 2018-11-22 シニュー・ファーマ・インコーポレイテッドＳｉＮｅｗ Ｐｈａｒｍａ Ｉｎｃ． 脂肪肝の予防または処置用医薬組成物
CA3090029A1 (en) * 2018-02-14 2019-08-22 Sinew Pharma Inc. Methods and compositions for preventing, reducing or eradicating toxicity caused by acetaminophen (apap)
JP6858729B2 (ja) * 2018-05-25 2021-04-14 ▲財▼▲団▼法人国防教育研究基金会Ｎａｔｉｏｎａｌ Ｄｅｆｅｎｓｅ Ｅｄｕｃａｔｉｏｎ Ａｎｄ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ 肝臓に対する副作用がない、新しいアセトアミノフェン複合組成
CN113164469A (zh) * 2018-09-03 2021-07-23 雅各生技有限公司 双那布扶林己二酸酯和乙酰胺酚的药物制剂及治疗疼痛的方法

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5584166A (en) * 1978-12-20 1980-06-25 Lion Hamigaki Kk Band for spongy medicine
ZA837556B (en) * 1982-11-15 1984-06-27 Upjohn Co Acetominophen and ibuprofen/flurbiprofen
JPS62502194A (ja) * 1985-03-18 1987-08-27 プロダクト・リソ−シズ・インタ−ナショナル・インコ−ポレイテッド エ−ロゾル発泡体
AU589991B2 (en) * 1985-08-26 1989-10-26 G.D. Searle & Co. Taste masking compositions
JPH01190628A (ja) * 1988-01-21 1989-07-31 Sumitomo Pharmaceut Co Ltd 持続性坐剤
FR2646773B1 (fr) * 1989-05-12 1994-05-13 Chauvin Sa Laboratoire Composition pharmaceutique a base de paracetamol
EP0527153B1 (en) * 1990-04-04 1996-07-24 Berwind Pharmaceutical Services, Inc. Aqueous maltodextrin and cellulosic polymer film coatings
ATE195252T1 (de) * 1993-04-23 2000-08-15 Novartis Erfind Verwalt Gmbh Wirkstoffabgabevorrichtung mit gesteuerter freigabe
US5733578A (en) * 1995-11-15 1998-03-31 Edward Mendell Co., Inc. Directly compressible high load acetaminophen formulations
WO1997044045A1 (en) * 1996-05-20 1997-11-27 Fuisz Technologies Ltd. Malatonin in combination with analgesics
US5858997A (en) * 1997-12-04 1999-01-12 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Method and composition for skin lightening
US8524277B2 (en) * 1998-03-06 2013-09-03 Alza Corporation Extended release dosage form
ES2153786B1 (es) * 1999-06-10 2001-10-16 S A L V A T Lab Sa Composicion farmaceutica liquida para la administracion oral de principios activos amargos y susceptibles de hidrolisis.
FR2798289B1 (fr) * 1999-09-15 2004-12-31 Cll Pharma Formes galeniques a delitement rapide en bouche et leur procede de preparation
BR0014966A (pt) * 1999-10-29 2002-07-02 Fmc Corp Composição de revestimento de pronta liberação, endurecìvel e comestìvel
ES2174734B1 (es) * 2000-11-03 2003-10-01 Belmac S A Lab Nueva formulacion galenica de paracetamol dispersable y soluble, procedimiento para su preparacion y aplicaciones.
MXPA04000209A (es) * 2001-07-10 2005-03-07 Teva Pharma Sistema de administracion para la administracion de droga de orden cero, bifasica de orden cero, ascendente o descendente.
BR0211794A (pt) * 2001-07-31 2004-11-03 Wyeth Corp Composição farmacêutica e método para mascarar o sabor de pelo menos um composto farmaceuticamente ativo de sabor desagradável
US7101572B2 (en) * 2001-12-07 2006-09-05 Unilab Pharmatech, Ltd. Taste masked aqueous liquid pharmaceutical composition
KR100522239B1 (ko) * 2002-07-16 2005-10-18 주식회사 서울제약 아세트아미노펜을 함유하는 제어방출성의 경구용 제제
KR100507771B1 (ko) * 2002-11-08 2005-08-17 한미약품 주식회사 난용성 감기약 활성 성분의 경구투여용 조성물 및 그의제조 방법
MXPA06003450A (es) * 2003-09-26 2006-08-31 Johnson & Johnson Recubrimiento de farmaco que proporciona alta carga del farmaco y metodos para proporcionar el mismo.
NZ546183A (en) * 2003-09-26 2011-04-29 Alza Corp Controlled release formulations exhibiting an ascending rate of release
GB0330255D0 (en) * 2003-12-31 2004-02-04 Vectura Ltd Multiparticulate formulations for oral delivery
WO2006129668A1 (ja) * 2005-05-30 2006-12-07 Meiji Seika Kaisha, Ltd. 糖衣を施した丸剤
US20080085314A1 (en) * 2005-07-29 2008-04-10 Shalaby Shalaby W Solid oral formulations for combination therapy
WO2007050631A2 (en) * 2005-10-25 2007-05-03 Cima Labs Inc. Dosage form with coated active
WO2007074472A2 (en) * 2005-12-27 2007-07-05 Jubilant Organosys Limited Mouth dissolving pharmaceutical composition and process for preparing the same using a high amount of silicon dioxide
US10022339B2 (en) * 2006-04-21 2018-07-17 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
GB0613925D0 (en) * 2006-07-13 2006-08-23 Unilever Plc Improvements relating to nanodispersions
RU2477995C2 (ru) * 2007-07-20 2013-03-27 Эбботт Гмбх Унд Ко.Кг Составы неопиоидных и ограниченных опиоидных аналгетиков
CA2711211A1 (en) * 2008-01-03 2009-07-09 Aft Pharmaceuticals Ltd. Oral pharmaceutical suspension comprising paracetamol and ibuprofen
EP2249808A2 (en) * 2008-01-11 2010-11-17 Cipla Limited Solid pharmaceutical dosage form
CN102137671B (zh) * 2008-07-23 2012-10-17 国防教育研究基金会 含异烟碱酰胺(isoniazid，INH)低副作用的新复方
JP5592902B2 (ja) * 2009-03-09 2014-09-17 カウンシル オブ サイエンティフィック アンド インダストリアル リサーチ 治療薬の徐放性組成物
JP2011046666A (ja) * 2009-08-28 2011-03-10 Lion Corp 医薬組成物
CN101695498A (zh) * 2009-10-26 2010-04-21 昆明理工大学 对乙酰氨基酚所致肝损伤保护药物及其应用
CA3065589C (en) * 2010-06-03 2022-04-26 Catalent Ontario Limited Multi phase soft gel capsules, apparatus and method thereof
SG190448A1 (en) * 2010-12-02 2013-07-31 Aptalis Pharmatech Inc Rapidly dispersing granules, orally disintegrating tablets and methods
CN103391781A (zh) * 2011-04-20 2013-11-13 国防教育研究基金会 无/低副作用的抗结核病药物复方
CN102988993B (zh) * 2011-09-13 2017-03-15 广东九明制药有限公司 复方对乙酰氨基酚片主要辅料的筛选和组成及其制备方法
JP5828280B2 (ja) * 2011-12-28 2015-12-02 ライオン株式会社 錠剤及びその製造方法
ES2414557B1 (es) 2012-01-16 2014-06-10 Novocat Farma, S.A. Composición acuosa de paracetamol para inyección
CN102600119B (zh) * 2012-02-07 2013-03-27 海南卫康制药(潜山)有限公司 一种小儿对乙酰氨基酚组合物
CN103110629B (zh) * 2013-02-19 2014-03-19 青岛正大海尔制药有限公司 复方酚麻美敏滴丸及其制备方法
WO2015070396A1 (zh) * 2013-11-13 2015-05-21 财团法人国防教育研究基金会 无肝副作用的对乙酰胺基酚新复方组合
CN107614475A (zh) * 2015-09-24 2018-01-19 欣耀生医股份有限公司 有效于治疗肝毒性及脂肪肝疾病的化合物及其用途
CA3090029A1 (en) * 2018-02-14 2019-08-22 Sinew Pharma Inc. Methods and compositions for preventing, reducing or eradicating toxicity caused by acetaminophen (apap)

Also Published As

Publication number Publication date
PL3069733T3 (pl) 2023-02-13
CN105188756A (zh) 2015-12-23
HRP20221344T1 (hr) 2022-12-23
EA029454B1 (ru) 2018-03-30
WO2015070396A1 (zh) 2015-05-21
PT3069733T (pt) 2022-11-09
DK3069733T3 (da) 2022-11-14
KR102017550B1 (ko) 2019-09-03
US11534416B2 (en) 2022-12-27
LT3069733T (lt) 2022-11-25
EP3069733A4 (en) 2017-08-23
CN105188756B (zh) 2020-06-12
EP4173619A2 (en) 2023-05-03
US20190262289A1 (en) 2019-08-29
EP3069733A1 (en) 2016-09-21
KR20150115846A (ko) 2015-10-14
EP3069733B1 (en) 2022-08-10
EA201591435A1 (ru) 2016-05-31
CN111904924A (zh) 2020-11-10
US10420737B2 (en) 2019-09-24
KR20170085607A (ko) 2017-07-24
US20170172950A1 (en) 2017-06-22
US20230082397A1 (en) 2023-03-16
ES2929945T3 (es) 2022-12-05
EP4173619A3 (en) 2023-07-19
HUE060309T2 (hu) 2023-02-28
KR101881074B1 (ko) 2018-08-17
JP2016520100A (ja) 2016-07-11

Similar Documents

Publication Publication Date Title
IL295091B1 (en) Solid solution mixtures
EP2980058A4 (en) COMPOSITION COMPRISING A VINYL GROUP BASED COMPOUND
DK2879511T3 (da) Fodertilsætningsstofsammensætning
EP2889350A4 (en) ADHESIVE COMPOSITION
PL2968214T3 (pl) Nowe kompozycje przeciwbólowe
HK1215717A1 (zh) 結構黏合劑組合物
EP3034613A4 (en) NOVEL SOPHOROLIPIDE COMPOUND AND COMPOSITION THEREOF
EP3006525A4 (en) ASPHALT-URETHANE COMPOSITION
GB201306984D0 (en) Composition
PL3069733T3 (pl) Nowa kompozycja związku stanowiącego acetaminofen niepowodująca w wątrobie działań niepożądanych
EP3066178A4 (en) GREASE COMPOSITION
GB201317105D0 (en) Novel Composition
GB201317196D0 (en) Composition
GB201307622D0 (en) Composition
AP2015008916A0 (en) Composition used to remove labels
HRP20182110T1 (hr) Sastav spojeva tiakumicina
PL3083808T3 (pl) Kompozycja uszczelniająca
GB201319923D0 (en) Novel composition
GB201310513D0 (en) Novel composition
GB201308502D0 (en) Composition
GB201301774D0 (en) Composition
GB201305622D0 (en) Composition
ZA201401705B (en) Coating composition for application to new plasterwork
HK1187487A2 (en) Sealant composition
GB201322510D0 (en) Novel composition